Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Tea tree oil (5%) body wash versus standard care (Johnson's Baby Softwash) to prevent colonization with methicillin-resistant Staphylococcus aureus in critically ill adults: a randomized controlled trial.

Blackwood B, Thompson G, McMullan R, Stevenson M, Riley TV, Alderdice FA, Trinder TJ, Lavery GG, McAuley DF.

J Antimicrob Chemother. 2013 May;68(5):1193-9. doi: 10.1093/jac/dks501. Epub 2013 Jan 7.

PMID:
23297395
2.

A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: research protocol.

Thompson G, Blackwood B, McMullan R, Alderdice FA, Trinder TJ, Lavery GG, McAuley DF.

BMC Infect Dis. 2008 Nov 28;8:161. doi: 10.1186/1471-2334-8-161.

3.
4.

Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus.

Caelli M, Porteous J, Carson CF, Heller R, Riley TV.

J Hosp Infect. 2000 Nov;46(3):236-7.

PMID:
11073734
5.

Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.

Robinson JO, Phillips M, Christiansen KJ, Pearson JC, Coombs GW, Murray RJ.

Clin Microbiol Infect. 2014 Jun;20(6):530-5. doi: 10.1111/1469-0691.12388. Epub 2013 Nov 14.

6.

Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.

Camus C, Sebille V, Legras A, Garo B, Renault A, Le Corre P, Donnio PY, Gacouin A, Perrotin D, Le Tulzo Y, Bellissant E.

Infection. 2014 Jun;42(3):493-502. doi: 10.1007/s15010-013-0581-1. Epub 2014 Jan 25.

7.

Incidence of and risk factors for community-associated methicillin-resistant Staphylococcus aureus acquired infection or colonization in intensive-care-unit patients.

Wang JT, Liao CH, Fang CT, Chie WC, Lai MS, Lauderdale TL, Chang SC.

J Clin Microbiol. 2010 Dec;48(12):4439-44. doi: 10.1128/JCM.00784-10. Epub 2010 Oct 6.

8.

Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: a nested case-control study.

Huang SS, Datta R, Rifas-Shiman S, Kleinman K, Placzek H, Lankiewicz JD, Platt R.

Crit Care. 2011;15(5):R210. doi: 10.1186/cc10445. Epub 2011 Sep 14.

9.

Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.

Sarikonda KV, Micek ST, Doherty JA, Reichley RM, Warren D, Kollef MH.

Crit Care Med. 2010 Oct;38(10):1991-5. doi: 10.1097/CCM.0b013e3181eeda3f.

PMID:
20683260
10.

Active surveillance testing and decontamination strategies in intensive care units to reduce methicillin-resistant Staphylococcus aureus infections.

Kurup A, Chlebicka N, Tan KY, Chen EX, Oon L, Ling TA, Ling ML, Hong JL.

Am J Infect Control. 2010 Jun;38(5):361-7. doi: 10.1016/j.ajic.2009.09.018. Epub 2010 Feb 26.

PMID:
20189267
11.

Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections.

Oztoprak N, Cevik MA, Akinci E, Korkmaz M, Erbay A, Eren SS, Balaban N, Bodur H.

Am J Infect Control. 2006 Feb;34(1):1-5.

PMID:
16443085
12.

Molecular epidemiologic analysis of methicillin-resistant Staphylococcus aureus isolates from bacteremia and nasal colonization at 10 intensive care units: multicenter prospective study in Korea.

Kwon JC, Kim SH, Park SH, Choi SM, Lee DG, Choi JH, Park C, Shin NY, Yoo JH.

J Korean Med Sci. 2011 May;26(5):604-11. doi: 10.3346/jkms.2011.26.5.604. Epub 2011 Apr 21.

13.

Risk factors for intensive care unit acquired nasal colonization of MRSA and its impact on MRSA infection.

Altınbas A, Shorbagi A, Ascıoglu S, Zarakolu P, Cetinkaya-Sardan Y.

J Clin Lab Anal. 2013 Sep;27(5):412-7. doi: 10.1002/jcla.21620.

PMID:
24038229
14.

Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units.

Kypraios T, O'Neill PD, Huang SS, Rifas-Shiman SL, Cooper BS.

BMC Infect Dis. 2010 Feb 16;10:29. doi: 10.1186/1471-2334-10-29.

15.

Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: results of a 2-center study involving 500 patients.

Camus C, Bellissant E, Legras A, Renault A, Gacouin A, Lavoué S, Branger B, Donnio PY, le Corre P, Le Tulzo Y, Perrotin D, Thomas R.

Infect Control Hosp Epidemiol. 2011 Nov;32(11):1064-72. doi: 10.1086/662180. Epub 2011 Sep 29.

PMID:
22011532
16.

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.

Goldberg E, Paul M, Talker O, Samra Z, Raskin M, Hazzan R, Leibovici L, Bishara J.

J Antimicrob Chemother. 2010 Aug;65(8):1779-83. doi: 10.1093/jac/dkq179. Epub 2010 May 27.

PMID:
20507860
17.

Universal rapid screening for methicillin-resistant Staphylococcus aureus in the intensive care units in a large community hospital.

Kjonegaard R, Fields W, Peddecord KM.

Am J Infect Control. 2013 Jan;41(1):45-50. doi: 10.1016/j.ajic.2012.01.038. Epub 2012 May 30.

PMID:
22651895
19.

Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.

Falcone M, Russo A, Venditti M, Novelli A, Pai MP.

Clin Infect Dis. 2013 Dec;57(11):1568-76. doi: 10.1093/cid/cit582. Epub 2013 Sep 17.

PMID:
24046298
20.

Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill.

Niven DJ, Laupland KB, Gregson DB, Church DL; S aureus Screening Initiative Group..

J Crit Care. 2009 Dec;24(4):583-9. doi: 10.1016/j.jcrc.2008.10.004. Epub 2009 Feb 13.

PMID:
19327313

Supplemental Content

Support Center